Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Management of Kidney Transplant Outpatients With COVID-19: A Single Center Experience

M. Matysková Kubišová, S. Dusilová Sulková, P. Moučka, A. Pokorná, M. Heislerová, I. Guňka, P. Navrátil, J. Pacovský, A. Malá, R. Šafránek

. 2024 ; 37 (-) : 12920. [pub] 20240926

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25004107

Patients undergoing kidney transplant are at risk of severe COVID-19. Our single-center retrospective analysis evaluated the outcomes of kidney transplant outpatients with COVID-19 who were managed with reduced immunosuppression and treatment with molnupiravir. Between January 2022 and May 2023, we included 93 patients (62 men, average age 56 years), serum creatinine 127 (101-153) μmol/L. Molnupiravir was administered, and immunosuppressive therapy was reduced immediately following the confirmation of SARS-CoV-2 infection by PCR, which was 2 (1-3) days after the onset of symptoms. Only three (3.2%) patients required hospitalization, and one patient died. Acute kidney injury was observed in two patients. During the follow-up period of 19 (15-22) months, there was no significant increase in proteinuria, no acute or new chronic graft rejection, and kidney graft function remained stable; serum creatinine was 124 (106-159) μmol/L post-COVID-19 infection and 128 (101-161) μmol/L at the end of the follow-up period. Our results demonstrate that early initiation of molnupiravir treatment combined with a temporary reduction in immunosuppressive therapy results in favorable clinical outcomes in patients with COVID-19, with preservation of good graft function and no episodes of graft rejection.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25004107
003      
CZ-PrNML
005      
20250206105132.0
007      
ta
008      
250121e20240926sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/ti.2024.12920 $2 doi
035    __
$a (PubMed)39391264
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Matysková Kubišová, Michaela $u Department of Nephrology, University Hospital Hradec Kralove, Hradec Králové, Czechia
245    10
$a Management of Kidney Transplant Outpatients With COVID-19: A Single Center Experience / $c M. Matysková Kubišová, S. Dusilová Sulková, P. Moučka, A. Pokorná, M. Heislerová, I. Guňka, P. Navrátil, J. Pacovský, A. Malá, R. Šafránek
520    9_
$a Patients undergoing kidney transplant are at risk of severe COVID-19. Our single-center retrospective analysis evaluated the outcomes of kidney transplant outpatients with COVID-19 who were managed with reduced immunosuppression and treatment with molnupiravir. Between January 2022 and May 2023, we included 93 patients (62 men, average age 56 years), serum creatinine 127 (101-153) μmol/L. Molnupiravir was administered, and immunosuppressive therapy was reduced immediately following the confirmation of SARS-CoV-2 infection by PCR, which was 2 (1-3) days after the onset of symptoms. Only three (3.2%) patients required hospitalization, and one patient died. Acute kidney injury was observed in two patients. During the follow-up period of 19 (15-22) months, there was no significant increase in proteinuria, no acute or new chronic graft rejection, and kidney graft function remained stable; serum creatinine was 124 (106-159) μmol/L post-COVID-19 infection and 128 (101-161) μmol/L at the end of the follow-up period. Our results demonstrate that early initiation of molnupiravir treatment combined with a temporary reduction in immunosuppressive therapy results in favorable clinical outcomes in patients with COVID-19, with preservation of good graft function and no episodes of graft rejection.
650    _2
$a lidé $7 D006801
650    12
$a transplantace ledvin $x škodlivé účinky $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ženské pohlaví $7 D005260
650    12
$a COVID-19 $x komplikace $7 D000086382
650    _2
$a retrospektivní studie $7 D012189
650    12
$a imunosupresiva $x terapeutické užití $7 D007166
650    _2
$a senioři $7 D000368
650    _2
$a dospělí $7 D000328
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a rejekce štěpu $7 D006084
650    _2
$a antivirové látky $x terapeutické užití $7 D000998
650    _2
$a pacienti ambulantní $7 D010045
650    _2
$a výsledek terapie $7 D016896
650    _2
$a kreatinin $x krev $7 D003404
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dusilová Sulková, Sylvie $u Department of Nephrology, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Moučka, Petr $u Department of Nephrology, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Pokorná, Anita $u Department of Nephrology, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Heislerová, Marcela $u Hospital Pharmacy, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Guňka, Igor $u Department of Surgery, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Navrátil, Pavel $u Department of Urology, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Pacovský, Jaroslav $u Department of Urology, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Malá, Alena $u Department of Nephrology, University Hospital Hradec Kralove, Hradec Králové, Czechia
700    1_
$a Šafránek, Roman $u Department of Nephrology, University Hospital Hradec Kralove, Hradec Králové, Czechia
773    0_
$w MED00004553 $t Transplant international $x 1432-2277 $g Roč. 37 (20240926), s. 12920
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39391264 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206105127 $b ABA008
999    __
$a ok $b bmc $g 2263700 $s 1240114
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 37 $c - $d 12920 $e 20240926 $i 1432-2277 $m Transplant international $n Transpl Int $x MED00004553
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace